Atlas Trials

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Clinical trial NCT01163383 · AVAILABLE

Trial details

NCT number
NCT01163383
Sponsor
John Maris
Status
AVAILABLE
Study type
EXPANDED_ACCESS
NeuroblastomaChildhood Metastatic Pheochromocytoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.